Facts and Statistics Overview. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS) or myeloproliferative neoplasms (MPNs).

Learn facts and statistics about blood cancer (leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms). Visit this page to gain more blood cancer knowledge.

The Leukemia & Lymphoma Society® (LLS) is the global leader and innovator in creating a world without blood cancer. The LLS mission: Cure blood cancer and improve the quality of life of all patients and their families.

The Leukemia & Lymphoma Society (LLS), a 501(c)(3) charitable organization founded in 1949, is a voluntary health organization dedicated to fighting blood cancer world-wide. LLS funds blood cancer research on cures for leukemia, lymphoma, Hodgkin's disease, and myeloma. It provides free information and support services, and it advocates for ...

Statistics and facts about blood cancers including leukemia, lymphoma, myeloma and myelodysplastic syndromes (MDS).

Search for topics. Donate; En Espanol; Main navigation (Mobile) About LLS. Who We Are. Who We Are

The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The LLS Mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients

The Leukemia & Lymphoma Society (LLS) is the world’s leading private organization funding blood cancer research. Our mission: Cure leukemia, lymphoma, Hodgkin’s disease and …

2024年12月19日 · Since its founding in 1949, The Leukemia & Lymphoma Society (LLS) has been at the forefront of the fight against blood cancers. What began as a small, family-driven initiative has grown into a global leader in cancer research, patient support, and advocacy.

The Leukemia & Lymphoma Society (LLS) is a national, voluntary health agency dedicated to curing leukemia, lymphoma, Hodgkin’s disease and myeloma, and to improving the quality of life of patients and their families. The society was established in 1949 as the de Villiers Foundation.